This review offers hospitalist physicians and healthcare providers involved in inpatient diabetes care a pathophysiologic-
based approach for the use of incretin agents in patients with hyperglycemia and diabetes, as well as a summary of benefits and concerns of insulin and incretinbased therapy in the hospital setting.